Development of an ErbB-overexpressing A-431 optical reporting tumor xenograft model to assess targeted photodynamic therapy regimens

Photochemistry and Photobiology

Volumn 86, Issue 6, 2010, Pages 1379-1389

  Savellano, Mark D ^a   Owusu Brackett, Nicci ^a   Son, Ji ^a   Callier, Thierri ^a   Savellano, Dagmar Högemann ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

ANIMAL; ARTICLE; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FEMALE; GENE VECTOR; GENETICS; HUMAN; INSTRUMENTATION; MOUSE; NUDE MOUSE; PHOTOCHEMOTHERAPY; PROTO ONCOGENE; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; GENES, ERBB-1; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUCIFERASES, FIREFLY; LUMINESCENT PROTEINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 78649643007     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2010.00805.x     Document Type: Article

References (39)

1. Salomon, D. S., R. Brandt, F. Ciardiello, and, N. Normanno, (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19, 183-232.
2. Janmaat, M. L., and, G. Giaccone, (2003) The epidermal growth factor receptor pathway and its inhibition as anticancer therapy. Drugs Today (Barc) 39 (Suppl. C), 61-80.
3. Mendelsohn, J., and, J. Baselga, (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19, 6550-6565.
4. Baselga, J., J. Albanell, M. A. Molina, and, J. Arribas, (2001) Mechanism of action of trastuzumab and scientific update. Semin. Oncol. 28, 4-11.
5. Wu, X., M. Rubin, Z. Fan, T. DeBlasio, T. Soos, A. Koff, and, J. Mendelsohn, (1996) Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene 12, 1397-1403.
6. Garnock-Jones, K. P., G. M. Keating, and, L. J. Scott, (2010) Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs 70, 215-239.
7. Boland, W. K., and, G. Bebb, (2009) Nimotuzumab: A novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity. Expert Opin. Biol. Ther. 9, 1199-1206.
8. Loew, S., U. Schmidt, A. Unterberg, and, M. E. Halatsch, (2009) The epidermal growth factor receptor as a therapeutic target in glioblastoma multiforme and other malignant neoplasms. Anticancer Agents Med. Chem. 9, 703-715.
9. Owonikoko, T. K., S. Y. Sun, and, S. S. Ramalingam, (2009) The role of cetuximab in the management of non-small-cell lung cancer. Clin. Lung Cancer 10, 230-238.
10. Yang, X. D., X. C. Jia, J. R. Corvalan, P. Wang, and, C. G. Davis, (2001) Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit. Rev. Oncol. Hematol. 38, 17-23.
11. Wu, M., A. Rivkin, and, T. Pham, (2008) Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer. Clin. Ther. 30, 14-30.
12. Mendelsohn, J., and, J. Baselga, (2006) Epidermal growth factor receptor targeting in cancer. Semin. Oncol. 33, 369-385. (Pubitemid 44142736)
13. Levitzki, A., and, A. Gazit, (1995) Tyrosine kinase inhibition: An approach to drug development. Science 267, 1782-1788.
14. Sirotnak, F. M., M. F. Zakowski, V. A. Miller, H. I. Scher, and, M. G. Kris, (2000) Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin. Cancer Res. 6, 4885-4892.
15. Giard, D. J., S. A. Aaronson, G. J. Todaro, P. Arnstein, J. H. Kersey, H. Dosik, and, W. P. Parks, (1973) In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl Cancer Inst. 51, 1417-1423.
16. Haigler, H., J. F. Ash, S. J. Singer, and, S. Cohen, (1978) Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc. Natl Acad. Sci. USA 75, 3317-3321. (Pubitemid 8389718)
17. Park, D. J., H. Nakamura, A. M. Chumakov, J. W. Said, C. W. Miller, D. L. Chen, and, H. P. Koeffler, (1994) Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 9, 1899-1906.
18. Barnes, D. W., (1982) Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell Biol. 93, 1-4.
19. Fleshker, S., D. Preise, V. Kalchenko, A. Scherz, and, Y. Salomon, (2008) Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate. Photochem. Photobiol. 84, 1231-1237.
20. Kishimoto, H., M. Zhao, K. Hayashi, Y. Urata, N. Tanaka, T. Fujiwara, S. Penman, and, R. M. Hoffman, (2009) In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc. Natl Acad. Sci. USA 106, 14514-14517.
21. Zhang, Q., Y. A. Yu, E. Wang, N. Chen, R. L. Danner, P. J. Munson, F. M. Marincola, and, A. A. Szalay, (2007) Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res. 67, 10038-10046.
22. Abels, C., (2004) Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem. Photobiol. Sci. 3, 765-771.
23. Perrotte, P., T. Matsumoto, K. Inoue, H. Kuniyasu, B. Y. Eve, D. J. Hicklin, R. Radinsky, and, C. P. Dinney, (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin. Cancer Res. 5, 257-265.
24. Petit, A. M., J. Rak, M. C. Hung, P. Rockwell, N. Goldstein, B. Fendly, and, R. S. Kerbel, (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151, 1523-1530.
25. Viloria-Petit, A., T. Crombet, S. Jothy, D. Hicklin, P. Bohlen, J. M. Schlaeppi, J. Rak, and, R. S. Kerbel, (2001) Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis. Cancer Res. 61, 5090-5101.
26. Savellano, M. D., and, T. Hasan, (2003) Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem. Photobiol. 77, 431-439.
27. Savellano, M. D., and, T. Hasan, (2005) Photochemical targeting of epidermal growth factor receptor: A mechanistic study. Clin. Cancer Res. 11, 1658-1668.
28. Gerber, D. E., and, H. Choy, (2010) Cetuximab in combination therapy: From bench to clinic. Cancer Metastasis Rev. 29, 171-180.
29. Merzlyak, E. M., J. Goedhart, D. Shcherbo, M. E. Bulina, A. S. Shcheglov, A. F. Fradkov, A. Gaintzeva, K. A. Lukyanov, S. Lukyanov, T. W. Gadella, and, D. M. Chudakov, (2007) Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nat. Methods 4, 555-557.
30. Stinski, M. F., (1992) Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence. U.S. patent 5,168,062.
31. Stinski, M. F., (1995) Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter regulatory DNA sequence. U.S. patent 5,385,839.
32. Abramoff, M. D., P. J. Magelhaes, and, S. J. Ram, (2004) Image processing with ImageJ. Biophotonics Int. 11, 36-42.
33. Sun, X., and, W. N. Leung, (2002) Photodynamic therapy with pyropheophorbide-a methyl ester in human lung carcinoma cancer cell: Efficacy, localization and apoptosis. Photochem. Photobiol. 75, 644-651.
34. Ray, P., R. Tsien, and, S. S. Gambhir, (2007) Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 67, 3085-3093.
35. Corbett, T. H., L. Polin, B. J. Roberts, A. J. Lawson, W. R. Leopold III, K. White, J. Kushner, J. Paluch, S. Hazeldine, R. Moore, J. Rake, and, J. P. Horwitz, (2002) Transplantable syngeneic rodent tumors: Solid tumors of mice. In Tumor Models in Cancer Research (Edited by, B. A. Teicher,), pp. 41-72. Humana Press Inc., Totowa, NJ.
36. Lim, H. J., D. Masin, N. L. McIntosh, T. D. Madden, and, M. B. Bally, (2000) Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors. J. Pharmacol. Exp. Ther. 292, 337-345.
37. Caceres, G., X. Y. Zhu, J. A. Jiao, R. Zankina, A. Aller, and, P. Andreotti, (2003) Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence 18, 218-223.
38. Chen, B., C. Crane, C. He, D. Gondek, P. Agharkar, M. D. Savellano, P. J. Hoopes, and, B. W. Pogue, (2008) Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int. J. Cancer 123, 695-701.
39. Moriyama, E. H., S. K. Bisland, L. Lilge, and, B. C. Wilson, (2004) Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. Photochem. Photobiol. 80, 242-249.